BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 10410154)

  • 1. [A case of lung cancer with hypercalcemia and renal failure responsive to pamidronate].
    Koshida H; Kametani T; Masuda S
    Gan To Kagaku Ryoho; 1999 May; 26(6):833-6. PubMed ID: 10410154
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of chemotherapy on hypercalcemia in breast and lung cancer patients.
    Hassan BA; Yusoff ZB; Hassali MA; Othman SB; Weiderpass E
    Asian Pac J Cancer Prev; 2012; 13(9):4373-8. PubMed ID: 23167346
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Treatment of hypercalcemia of malignancy with pamidronate in a patient with advanced recurrent oral cancer].
    Nishimura N; Matsushita Y; Takaoka K; Hashitani S; Noguchi K; Urade M
    Gan To Kagaku Ryoho; 2002 Dec; 29(13):2537-9. PubMed ID: 12506478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased renal calcium reabsorption by parathyroid hormone-related protein is a causative factor in the development of humoral hypercalcemia of malignancy refractory to osteoclastic bone resorption inhibitors.
    Onuma E; Azuma Y; Saito H; Tsunenari T; Watanabe T; Hirabayashi M; Sato K; Yamada-Okabe H; Ogata E
    Clin Cancer Res; 2005 Jun; 11(11):4198-203. PubMed ID: 15930357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Childhood cancer and hypercalcemia: report of a case treated with pamidronate.
    Kutluk MT; Hazar V; Akyüz C; Varan A; Büyükpamukçu M
    J Pediatr; 1997 May; 130(5):828-31. PubMed ID: 9152297
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypercalcemia of malignancy.
    Body JJ
    Semin Nephrol; 2004 Jan; 24(1):48-54. PubMed ID: 14730509
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Respiratory failure due to pulmonary lymphangitis carcinomatosis.
    Fujita J; Yamagishi Y; Kubo A; Takigawa K; Yamaji Y; Takahara J
    Chest; 1993 Mar; 103(3):967-8. PubMed ID: 8449110
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of refractory cancer-associated hypercalcemia with aminohydroxypropylidene diphosphonate.
    Heaf JG; Hansen M
    Acta Med Scand; 1988; 224(3):287-8. PubMed ID: 3239457
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination of calcitonin and pamidronate for emergency treatment of malignant hypercalcemia.
    Sekine M; Takami H
    Oncol Rep; 1998; 5(1):197-9. PubMed ID: 9458321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Significance of plasma PTH-rp in patients with hypercalcemia of malignancy treated with bisphosphonate.
    Wimalawansa SJ
    Cancer; 1994 Apr; 73(8):2223-30. PubMed ID: 8156530
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypercalcemia and childhood cancer: a 7-year experience.
    Kerdudo C; Aerts I; Fattet S; Chevret L; Pacquement H; Doz F; Michon J; Garabedian M; Orbach D
    J Pediatr Hematol Oncol; 2005 Jan; 27(1):23-7. PubMed ID: 15654274
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Severe prolonged hypocalcaemia following pamidronate for malignant hypercalcaemia.
    Sims EC; Rogers PB; Besser GM; Plowman PN
    Clin Oncol (R Coll Radiol); 1998; 10(6):407-9. PubMed ID: 9890546
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Update on the medical treatment of hypercalcemia of malignancy.
    Hall TG; Schaiff RA
    Clin Pharm; 1993 Feb; 12(2):117-25. PubMed ID: 8453860
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Undifferentiated pancreatic cancer associated with humoral hypercalcemia of malignancy.
    Kakizaki S; Ohya N; Yoshinaga T; Higuchi T; Kitazawa R; Takayama H; Takagi H; Nagamine T; Mori M
    Jpn J Clin Oncol; 1998 Sep; 28(9):563-6. PubMed ID: 9793031
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disodium pamidronate for treating severe hypercalcemia in a hemodialysis patient.
    Trimarchi H; Lombi F; Forrester M; Elizondo C; Sawinski D; Pereyra H; Freixas E
    Nat Clin Pract Nephrol; 2006 Aug; 2(8):459-63; quiz 464. PubMed ID: 16932480
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of combination treatment with a vitamin D analog (OCT) and a bisphosphonate (AHPrBP) in a nude mouse model of cancer-associated hypercalcemia.
    Endo K; Katsumata K; Iguchi H; Kubodera N; Teramoto T; Ikeda K; Fujita T; Ogata E
    J Bone Miner Res; 1998 Sep; 13(9):1378-83. PubMed ID: 9738509
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Parathyroid hormone-related protein(50-69) and response to pamidronate therapy for tumour-induced hypercalcaemia.
    Dodwell DJ; Abbas SK; Morton AR; Howell A
    Eur J Cancer; 1991; 27(12):1629-33. PubMed ID: 1782072
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of acute lymphoblastic leukemia-induced extreme hypercalcemia with pamidronate and calcitonin.
    Mathur M; Sykes JA; Saxena VR; Rao SP; Goldman GM
    Pediatr Crit Care Med; 2003 Apr; 4(2):252-5. PubMed ID: 12749663
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A case of myeloma with hypercalcemia caused by high serum concentrations of both parathyroid hormone-related peptide (PTHrP) and macrophage inflammatory protein-1α (MIP-1α).
    Shimizu H; Monden T; Tomotsune T; Nakatani Y; Domeki N; Matsumura M; Jojima T; Kawagoe Y; Kasai K
    Intern Med; 2011; 50(24):2993-6. PubMed ID: 22185991
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disodium pamidronate in the preoperative treatment of hypercalcemia in patients with primary hyperparathyroidism.
    Jansson S; Tisell LE; Lindstedt G; Lundberg PA
    Surgery; 1991 Sep; 110(3):480-6. PubMed ID: 1845370
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.